Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Vir Biotechnology Inc shares valued at $625 were sold by de Verneuil Vanina on Dec 02 ’24. At $8.22 per share, de Verneuil Vanina sold 76 shares. The insider’s holdings dropped to 56,973 shares worth approximately $0.41 million following the completion of this transaction.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, VANINA ALEXANDRA HUARD DE VERN purchased 76 shares, netting a total of over 625 in proceeds.
Before that, de Verneuil Vanina had sold 4,397 shares from its account. In a trade valued at $44,454, the EVP and General Counsel traded Vir Biotechnology Inc shares for $10.11 each. Upon closing the transaction, the insider’s holdings decreased to 4,397 shares, worth approximately $0.41 million.
As published in a research note from JP Morgan on January 29, 2024, Vir Biotechnology Inc [VIR] has been rated down from an Overweight to a Neutral and the price target has been revised to $9 from $23. Analysts at BofA Securities downgraded the stock from ‘”a Buy”‘ to ‘”a Neutral”‘ outlook in a report released in early September. As of March 06, 2023, JP Morgan has increased its “Neutral” rating to a “an Overweight” for VIR. Earlier on February 21, 2023, Goldman upgraded its rating. Their new recommendation was “a Buy” for VIR stock which previously was a “a Neutral”.
Analyzing VIR Stock Performance
During the last five days, there has been a drop of approximately -8.50%. Over the course of the year, Vir Biotechnology Inc shares have dropped approximately -28.88%. Shares of the company reached a 52-week high of $13.09 on 06/05/24 and a 52-week low of $6.56 on 11/21/24. A 50-day SMA is recorded $8.02, while a 200-day SMA reached $8.92. Nevertheless, trading volume fell to 1.04 million shares from 1.14 million shares the previous day.
Support And Resistance Levels for Vir Biotechnology Inc (VIR)
According to the 24-hour chart, there is a support level at 6.92, which, if violated, would cause prices to drop to 6.69. In the upper region, resistance lies at 7.50. The next price resistance is at 7.85. RSI (Relative Strength Index) is 41.21 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -0.61, which suggests the price will decrease in the coming days. Percent R is at 95.62%, indicating bearish price movement. Stochastics %K at buying indicates that the stock is to be held.
